Primeadine
Primeadine

Hyperbaric oxygen therapy: a commercial Longevity treatment?

Hyperbaric oxygen therapy can significantly decrease aging characteristics – does it have a future as a commercial Longevity treatment? Aging is made up of many...

Senescence: a new weapon in the fight against cancer

Targeting senescent “zombie” cells may improve cancer survival rates. How well women with cervical cancer respond to treatment (and survive) correlates with the level of...

Wearables and AI on the frontline of Longevity

0
Disruptive platforms are set for huge growth ahead of the inevitable consolidation and acquisitions: the...

The time is right for specialist Longevity investment

0
We speak to the co-founder of LongeVC – an investment firm focused exclusively on Longevity. Earlier...

Would you invest $1000 per week to live longer?

0
Money can't buy happiness - but it can buy Longevity;  this updated report from UBS...

Exclusive: ChromaDex’s CEO on Longevity commercialisation

0
ChromaDex CEO Rob Fried on regulatory approval, scaling-up and going global. LA-based ChromaDex is a global...

Investing in the age of Longevity: Investment panel

0
The Longevity Week: Master Investor Masterclass The Investment Panel investigates demonstrated Longevity growth, name-checking some hot...